The Government Sat on This Alcohol Study. The Data Says Why.

A federally commissioned study on alcohol and health sat unreleased for reasons the administration never fully explained. Then it showed up anyway — not through a leak, but through the process science is actually supposed to use: independent peer review. The Alcohol Intake and Health Study was published June 9 in the Journal of Studies on Alcohol and Drugs, and its central finding is the one the industry least wants normalized: there is no level of alcohol consumption the data can call safe.

A government can decline to publish a finding. It cannot make the finding untrue in the meantime.

The expert panel — convened in 2023, its work completed well before the administration’s decision to withhold it — found that even roughly one drink per day is associated with measurably elevated risk of death from liver cirrhosis, esophageal and oral cancers, and alcohol-related injury. At 14 drinks a week, the study estimates men face roughly a 1-in-25 lifetime risk of alcohol-attributable death. Women, drinking the same amount, face more than double men’s risk of alcohol-related liver disease — a sex-based gap in physiological harm that most public health messaging still doesn’t reflect back to drinkers making their own risk calculations. STAT News and CNN both confirmed the panel’s process and timeline independently, which matters here: this isn’t one outlet’s characterization of a leaked document, it’s two newsrooms verifying the same finding against the same publicly available peer-reviewed text.

One named source went further than the data itself. “These findings are not radical,” said Robert Vincent, commenting on the study’s reception. “They are rigorous — and commercially threatening.” That’s a specific, falsifiable claim worth taking seriously rather than waving off as advocacy: an industry that has spent decades marketing moderate drinking as heart-healthy has a direct financial stake in a study concluding otherwise, and “commercially threatening” is a plainer way of saying “expensive to acknowledge.” Vincent’s second point cuts closer to why this matters for anyone working in treatment or public health right now: “The public health consequences of sidelining evidence-based alcohol policy are immediate and cumulative.” Delay isn’t neutral. Every month a finding like this sits in a drawer is a month of drinking decisions made without it.

The obesity finding nobody’s connecting to the first one

The suppressed study didn’t land in isolation. Two months earlier, JAMA Internal Medicine published a nationally representative analysis by Shuey and colleagues finding that nearly 1 in 10 U.S. adults in 2023 reported overlapping heavy drinking and obesity — a combination that compounds risk for alcohol-associated liver disease specifically, rather than simply adding two separate risk factors together. The association held across age, sex, and racial groups, but it was strongest among uninsured and Medicaid-enrolled populations — exactly the group with the least buffer, financially or medically, to absorb a liver disease diagnosis that could have been caught earlier.

Read together, the two studies say something neither says alone: alcohol’s harm profile is dose-dependent with no lower safety floor, and it’s compounding fastest in the population least equipped to treat the consequences. That’s not a reason for shame — plenty of people managing both heavy drinking and obesity are already carrying more stigma than help. It’s a reason clinicians screening for one condition should be routinely screening for the other, and a reason insurers structuring coverage around either diagnosis in isolation are missing exactly the patients most at risk.

What this doesn’t say, and what it does

Neither study is an argument for panic, and neither is new in kind — researchers have been narrowing the “safe drinking” threshold for years as better data accumulates. What’s new is the fight over whether the public got to see this specific piece of that accumulating picture on schedule, or several months late and only because peer review doesn’t answer to a press office. For an audience of providers, case managers, and people managing their own drinking, the actionable read is simple: “no safe level” doesn’t mean every drink is equally dangerous, and it doesn’t mean moderate drinkers need to panic retroactively. It means the old advice — a glass of wine is heart-healthy, one drink a day is essentially risk-free — was never as settled as it sounded, and the data saying so was sitting in a drawer while people kept hearing it anyway.

Neither study is an argument for panic, and neither is new in kind — researchers have been narrowing the “safe drinking” threshold for years as better data accumulates.